Comparison of Two Types of Braces in the Treatment of Rockwood Type III AC-dislocations
Launched by BÜRGERSPITAL SOLOTHURN · Aug 24, 2017
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • First acute acromioclavicular dislocation Rockwood Type III
- Exclusion Criteria:
- • Previous injury to acromioclavicular Joint
- • Previous surgery of acromioclavicular Joint
- • Known hypersensitivity or allergy to fabric of investigational product
- • Pregnancy
- • Known or suspected non-compliance, drug or alcohol abuse
- • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
About Bürgerspital Solothurn
Bürgerspital Solothurn is a renowned healthcare institution located in Solothurn, Switzerland, committed to advancing medical research and improving patient care through innovative clinical trials. As a sponsor of clinical research, Bürgerspital Solothurn emphasizes rigorous scientific methodology, ethical standards, and patient safety, aiming to contribute valuable data to the medical community. The institution collaborates with a network of healthcare professionals and researchers to explore new treatments and therapies, fostering an environment of excellence in clinical practice and research. With a focus on collaboration and community health, Bürgerspital Solothurn plays a pivotal role in enhancing the quality of healthcare both locally and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Solothurn, , Switzerland
Patients applied
Trial Officials
Näder Helmy, PD, MD
Study Chair
Bürgerspital Solothurn, Department of Orthopaedics and Traumatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials